Gene:
ABCC1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1

Overview

Alternate Names: ATP-binding cassette, sub-family C, member 1; Human multidrug resistance-associated protein (MRP) mRNA, complete cds.; LTC4 transporter; OTTHUMP00000045904; leukotriene C(4) transporter; multidrug resistance protein; multiple drug resistance protein 1; multiple drug resistance-associated protein
Alternate Symbols: ABC29; ABCC; DKFZp686N04233; DKFZp781G125; GS-X; L05628.1; MRP; MRP1
PharmGKB Accession Id: PA244

Details

Cytogenetic Location: chr16 : p13.11
GP mRNA Boundary: chr16 : 15950935 - 16143774
GP Gene Boundary: chr16 : 15940935 - 16146774
Strand: plus
Product Name: ATP-binding cassette, sub-family C, member 1, ATP-binding cassette, sub-family C, member 1 isoform 1, ATP-binding cassette, sub-family C, member 1 isoform 2, ATP-binding cassette, sub-family C, member 1 isoform 3, ATP-binding cassette, sub-family C, member 1 isoform 4, ATP-binding cassette, sub-family C, member 1 isoform 5, ATP-binding cassette, sub-family C, member 1 isoform 6, ATP-binding cassette, sub-family C, member 1 isoform 7, multidrug resistance protein, multiple drug resistance protein 1, multiple drug resistance-associated protein
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

Curated Annotations (Curated Annotation)

  1. rs119774 at chr16:15994334 in ABCC1
    Associations were found between genotypes of SNPs in the ALOX5 (rs2115819) and MRP1 (rs119774) genes and changes in FEV(1) (p < 0.05) in asthma patients treated with montelukast.
    Variant Name:
    MRP1 (rs119774)
    Related Drugs:
    montelukast
    Related Diseases:
    Asthma
    Evidence:
    PMID:16293801
  2. rs3784862 at chr16:16018392 in ABCC1
    SNP is associated with the onset of toxicity to methotrexate in patients with psoriasis.
    Related Drugs:
    methotrexate
    Related Diseases:
    Psoriasis
    Evidence:
    PMID:18256692
  3. rs246240 at chr16:16026525 in ABCC1
    SNP is associated with the onset of toxicity to methotrexate in patients with psoriasis.
    Related Drugs:
    methotrexate
    Related Diseases:
    Psoriasis
    Evidence:
    PMID:18256692
  4. rs246240 at chr16:16026525 in ABCC1
    SNP is associated with development of hepatic or gastrointestinal toxicity to methotrexate in patients with psoriasis.
    Related Drugs:
    methotrexate
    Evidence:
    PMID:18256692
  5. rs35592 at chr16:16049324 in ABCC1
    SNP influences the efficacy of methotrexate in patients with psoriasis.
    Related Drugs:
    methotrexate
    Evidence:
    PMID:18256692
  6. rs35621 at chr16:16076109 in ABCC1
    This SNP in intron 14 of the ABCC1 gene was significantly associated with a highly excessive forced expiratory volume in 1s (FEV1) decline in Doetinchem (n = 1152) and Vlagtwedde-Vlaardingen (n = 1390) cohorts.
    Related Diseases:
    Pulmonary Disease, Chronic Obstructive
    Evidence:
    PMID:19687781
  7. rs45511401 at chr16:16080733 in ABCC1
    Risk or phenotype-associated allele: 2012GT (671Gly/Val) genotype. Phenotype: Carriers the heterozygous 2012GT (671Gly/Val) genotype had lower serum HDL cholesterol than the GG (671Gly/Gly) genotype carriers (p = 0.015). Study size: 136. Study population/ethnicity: Hypercholesterolemic individuals, treated with atorvastatin (10mg/day/4 weeks), evaluated for CAD risk factors at the Institute Dante Pazzanese of Cardiology and the Hospital of the Sao Paulo University in Sao Paulo City, Brazil. Significance metric(s): p = 0.015. Type of association: GN; PD; FA
    Variant Name:
    ABCC1:2012G>T, mRNA 2187G>T, Gly671Val
    Related Drugs:
    atorvastatin
    Related Diseases:
    Coronary Artery Disease, Hypercholesterolemia
    Evidence:
    PMID:18851956
  8. rs45511401 at chr16:16080733 in ABCC1
    system: membrane vessicles from HEK cells transfected with WT and variant; FA: transport of leukotriene C4, 17beta-estradiol 17beta-(D)-glucuronide, and estrone sulfate were the same for WT and variant
    Variant Name:
    G671V
    Related Drugs:
    estradiol, estrone
    Evidence:
    PMID:11721885
  9. rs4148356 at chr16:16084776 in ABCC1
    system: membrane vessicles from HEK cells transfected with WT or variant; FA: variant had approx 50% decrease in transport of tritium labelled 17[beta]-estradiol-17[beta]-D-glucuronide and tritium labelled methotrexate
    Variant Name:
    Arg723Gln
    Related Drugs:
    methotrexate
    Evidence:
    PMID:16041243
  10. rs35529209 at chr16:16112826 in ABCC1
    system: membrane vessicles from HEK cells transfected with WT or variant; FA: variant had approx 50% decrease in transport of tritium labelled 17[beta]-estradiol-17[beta]-D-glucuronide (17E2b-g) due to decrease in Km
    Variant Name:
    Ala989Thr
    Related Drugs:
    estradiol
    Evidence:
    PMID:16041243
  11. rs2238476 at chr16:16121373 in ABCC1
    SNP influences the efficacy of methotrexate in patients with psoriasis.
    Related Drugs:
    methotrexate
    Evidence:
    PMID:18256692
  12. rs28364006 at chr16:16135750 in ABCC1
    SNP influences the efficacy of methotrexate in patients with psoriasis.
    Related Drugs:
    methotrexate
    Related Diseases:
    Psoriasis
    Evidence:
    PMID:18256692
  13. rs212093 at chr16:16145255 in ABCC1
    This SNP in the 3' region of the ABCC1 gene was significantly associated with a lower forced expiratory volume in 1s in Doetinchem (n = 1152) and Vlagtwedde-Vlaardingen (n = 1390) cohorts.
    Related Diseases:
    Pulmonary Disease, Chronic Obstructive
    Evidence:
    PMID:19687781
  14. rs4148382 at chr16:16145995 in ABCC1
    This SNP in the 3' region of the ABCC1 gene was significantly associated with a higher forced expiratory volume in 1s in Doetinchem (n = 1152) and Vlagtwedde-Vlaardingen (n = 1390) cohorts.
    Related Diseases:
    Pulmonary Disease, Chronic Obstructive
    Evidence:
    PMID:19687781

Non-Curated Annotations (Non-Curated Annotation)

  1. rs3765129 at chr16:16057402 in ABCC1
    Approximately 50% of the variation in absolute neutrophil count nadir in cancer patients is explained by rs3765129, rs2306283 and UGT1a1*93.
    Variant Name:
    ABCC1: IVS11 ¿48C>T
    Related Diseases:
    Neoplasms
    Evidence:
    PMID:19940846
  2. rs35605 at chr16:16069520 in ABCC1
    The AUCs of irinotecan, SN-38, SN-38 glucuronide, and APC are influenced by rs3740066, rs2306283, rs35605, rs10276036, and rs717620 .
    Variant Name:
    ABCC1: 1684C>T
    Related Drugs:
    irinotecan, SN-38
    Evidence:
    PMID:19940846
Variant names are different names that have been used in the literature and other resources to refer to the same variant. Non-curated variant information is accumulated solely by computational methods and has not been verified by the scientific staff at PharmGKB.

Non-Curated Information

A list of non-curated publications that mention this gene along with other genes is available.

Curated Information

The following drugs are in curated knowledge about this gene.

  Drug Class Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
anthracyclines and related substances
  • CO
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
antineoplastic agents
  •   
  • PD
  • PK
  • FA
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
estrogens
  •   
  •   
  • PK
  •   
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Imidazothiazole derivatives
  • CO
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
vinca alkaloids and analogues
  •   
  •   
  • PK
  •   
  •   
Pathways
  Drug Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
atorvastatin
  •   
  • PD
  •   
  • FA
  • GN
Publications, Variants
No phenotype data No genotype data Literature annotations available Not annotated
Biricodar
  • CO
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
calcein
  • CO
  •   
  •   
  • FA
  •   
Publications
Phenotype data available No genotype data Literature annotations available Not annotated
carboplatin
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
carmustine
  • CO
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
chlorambucil
  •   
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
colchicine
  •   
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
cyanocobalamin
  •   
  • PD
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
cytarabine
  • CO
  •   
  •   
  • FA
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
daunorubicin
  • CO
  •   
  •   
  • FA
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
dexamethasone
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
digoxin
  •   
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data No literature annotations Not annotated
dimethyl sulfoxide
  •   
  • PD
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
docetaxel
  • CO
  • PD
  • PK
  •   
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
doxorubicin
  • CO
  • PD
  • PK
  • FA
  •   
Publications, Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
epirubicin
  •   
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
estradiol
  •   
  •   
  •   
  •   
  •   
Variants
Phenotype data available Genotype Data Available Literature annotations available Not annotated
estrone
  •   
  •   
  •   
  •   
  •   
Variants
No phenotype data No genotype data Literature annotations available Not annotated
ethacrynic acid
  • CO
  •   
  •   
  • FA
  •   
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
etoposide
  • CO
  • PD
  • PK
  • FA
  • GN
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
folic acid
  •   
  • PD
  • PK
  • FA
  •   
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
genistein
  • CO
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
idarubicin
  • CO
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
imatinib
  • CO
  •   
  •   
  • FA
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
indomethacin
  • CO
  •   
  •   
  • FA
  •   
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
irinotecan
  •   
  • PD
  • PK
  • FA
  • GN
Publications, Pathways
Phenotype data available No genotype data Literature annotations available Not annotated
leucovorin
  •   
  • PD
  • PK
  • FA
  •   
Publications, Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
methotrexate
  • CO
  • PD
  • PK
  • FA
  • GN
Publications, Pathways, Variants
No phenotype data No genotype data Literature annotations available Not annotated
mitoxantrone
  • CO
  •   
  •   
  • FA
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
MK-571
  • CO
  •   
  •   
  • FA
  •   
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
montelukast
  • CO
  • PD
  •   
  •   
  • GN
Publications, Variants
No phenotype data No genotype data Literature annotations available Not annotated
paclitaxel
  • CO
  • PD
  • PK
  • FA
  • GN
Publications, Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
probenecid
  • CO
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
pyridoxine
  •   
  • PD
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
rifampin
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
vinblastine
  •   
  •   
  • PK
  • FA
  •   
Publications, Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
vincristine
  • CO
  •   
  • PK
  • FA
  • GN
Publications, Pathways
No phenotype data No genotype data No literature annotations Not annotated
vindesine
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
vinorelbine
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
zileuton
  •   
  • PD
  •   
  •   
  • GN
Publications

Non-Curated Information

A list of non-curated publications that mention this gene along with other drugs is available.

Curated Information

The following diseases are in curated knowledge about this gene.

  Disease Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
Adenocarcinoma
  •   
  • PD
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Arthritis, Rheumatoid
  •   
  • PD
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Asthma
  • CO
  • PD
  •   
  •   
  • GN
Publications, Variants
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Brain Neoplasms
  •   
  • PD
  •   
  • FA
  •   
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Breast Neoplasms
  •   
  • PD
  • PK
  • FA
  •   
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Cardiomyopathy, Dilated
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Cardiomyopathy, Hypertrophic
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data No literature annotations Not annotated
Cardiomyopathy, Restrictive
  •   
  • PD
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data No literature annotations Not annotated
Chagas Cardiomyopathy
  •   
  • PD
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Colonic Neoplasms
  •   
  • PD
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Coronary Artery Disease
  •   
  • PD
  •   
  • FA
  • GN
Publications, Variants
No phenotype data No genotype data Literature annotations available Not annotated
Diarrhea
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Hodgkin Disease
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Hypercholesterolemia
  •   
  • PD
  •   
  • FA
  • GN
Publications, Variants
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Leukemia
  • CO
  •   
  •   
  • FA
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • CO
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Leukemia, Myeloid
  • CO
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Leukemia, Myeloid, Acute
  • CO
  •   
  •   
  • FA
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Lung Neoplasms
  •   
  • PD
  • PK
  • FA
  •   
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Lymphoma
  •   
  • PD
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Lymphoma, Non-Hodgkin
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Melanoma
  •   
  • PD
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Multiple Myeloma
  •   
  •   
  • PK
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Neoplasms
  • CO
  • PD
  • PK
  • FA
  •   
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Neutropenia
  •   
  •   
  • PK
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Ovarian Neoplasms
  •   
  • PD
  • PK
  • FA
  •   
Publications, Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • CO
  • PD
  • PK
  • FA
  •   
Publications, Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Prostatic Neoplasms
  •   
  • PD
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Psoriasis
  • CO
  • PD
  • PK
  •   
  • GN
Publications, Variants
No phenotype data No genotype data Literature annotations available Not annotated
Pulmonary Disease, Chronic Obstructive
  •   
  •   
  •   
  •   
  • GN
Publications, Variants

Non-Curated Information

A list of non-curated publications that mention this gene along with other diseases is available.

Curated Phenotype Datasets

These datasets are sorted alphabetically by title.

The PharmGKB is financially supported by the NIH/ NIGMS and is managed at Stanford University (U01GM61374).
©2001-2010 PharmGKB.